SCHEMBL14212096

SCHEMBL14212096

CC(C)(C)n1cc(-c2cccc(C(=O)O)c2)nn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 8/20 0.51
▸ ORAI1 Q96D31 8/20 0.51
▸ KEAP1 Q14145 1/20 0.49
▸ NFE2L2 Q16236 1/20 0.49
▸ RXRA P19793 1/20 0.49
▸ RXRB P28702 1/20 0.49
▸ LDHA P00338 2/20 0.48
▸ UCHL1 P09936 1/20 0.46
▸ UCHL3 P15374 1/20 0.46
▸ UCHL5 Q9Y5K5 1/20 0.46
▸ KMO O15229 1/20 0.46
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA4 P22748 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ TRPC1 P48995 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22530587 0.84 P2RY14 (0.49) RXRARXRBNPC1RAB9ASMN1; SMN2
SCHEMBL15835844 0.79 CHRNB2 (0.47) KMOCA9
SCHEMBL14233963 0.77 UCHL5 (0.58) STIM1ORAI1KEAP1NFE2L2LDHA
SCHEMBL26156421 0.77 CYP19A1 (0.45) NPC1RAB9ASMN1; SMN2TSHR
SCHEMBL14212103 0.74 GPR55 (0.39) STIM1ORAI1KEAP1NFE2L2NPC1
SCHEMBL26803794 0.74 STIM1 (0.69) STIM1ORAI1KEAP1NFE2L2LDHA
SCHEMBL29946192 0.73 STIM1 (0.76) STIM1ORAI1KEAP1NFE2L2LDHA
SCHEMBL26628304 0.73 STIM1 (0.76) STIM1ORAI1KEAP1NFE2L2LDHA
SCHEMBL21470628 0.73 MIF (0.51) SMN1; SMN2HDAC3HDAC4HDAC1HDAC7
SCHEMBL22530445 0.72 P2RY14 (0.45) RXRARXRBNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120309794-A1 COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS UNIVERSITÀ DI PISA (IT) 2012-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309794-A1 COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS LDHA, LDHB, DLD STIM1 2377/4885ORAI1 2350/4885KEAP1 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback